Gaetano Finocchiaro

84.5k total citations · 2 hit papers
214 papers, 8.2k citations indexed

About

Gaetano Finocchiaro is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Gaetano Finocchiaro has authored 214 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Molecular Biology, 88 papers in Genetics and 53 papers in Oncology. Recurrent topics in Gaetano Finocchiaro's work include Glioma Diagnosis and Treatment (85 papers), Immunotherapy and Immune Responses (28 papers) and Metabolism and Genetic Disorders (27 papers). Gaetano Finocchiaro is often cited by papers focused on Glioma Diagnosis and Treatment (85 papers), Immunotherapy and Immune Responses (28 papers) and Metabolism and Genetic Disorders (27 papers). Gaetano Finocchiaro collaborates with scholars based in Italy, United States and France. Gaetano Finocchiaro's co-authors include Serena Pellegatta, Bianca Pollo, Maria Grazia Bruzzone, Marica Eoli, Stefano DiDonato, Jinan Behnan, Gabi Hanna, Sara Benedetti, Kay Tanaka and Federica Pisati and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Gaetano Finocchiaro

209 papers receiving 8.1k citations

Hit Papers

Clonal evolution of glioblastoma under therapy 2015 2026 2018 2022 2016 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clonal evolution of glioblastoma under therapy
    2016 485 citations Marica Eoli, Gaetano Finocchiaro et al. profile →
  2. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
    2015 471 citations Gaetano Finocchiaro et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaetano Finocchiaro Italy 51 3.9k 3.2k 2.2k 1.6k 1.2k 214 8.2k
Monica Nistér Sweden 50 5.5k 1.4× 1.7k 0.5× 2.4k 1.1× 1.9k 1.1× 789 0.6× 160 9.1k
Sandra Pastorino United States 32 3.0k 0.8× 1.7k 0.5× 1.8k 0.8× 1.8k 1.1× 718 0.6× 59 6.3k
Brian Patrick O’Neill United States 54 1.6k 0.4× 5.0k 1.5× 1.4k 0.6× 663 0.4× 434 0.3× 164 9.4k
Bianca Pollo Italy 42 1.9k 0.5× 2.5k 0.8× 1.3k 0.6× 772 0.5× 719 0.6× 167 5.4k
Roberto Pallini Italy 43 3.2k 0.8× 1.9k 0.6× 1.6k 0.7× 1.6k 1.0× 484 0.4× 237 7.3k
Shakti Ramkissoon United States 37 2.8k 0.7× 1.8k 0.6× 1.6k 0.7× 1.9k 1.1× 761 0.6× 204 6.9k
Donald M. O’Rourke United States 53 3.4k 0.9× 3.4k 1.0× 2.0k 0.9× 1.8k 1.1× 1.3k 1.0× 210 8.9k
Andrew J. Connolly United States 42 3.0k 0.8× 1.4k 0.4× 1.5k 0.7× 919 0.6× 1.9k 1.6× 88 8.0k
Karl H. Plate Germany 68 10.8k 2.8× 2.6k 0.8× 3.1k 1.4× 6.0k 3.6× 1.6k 1.3× 159 17.1k
Davide Schiffer Italy 49 3.2k 0.8× 2.9k 0.9× 1.0k 0.5× 1.0k 0.6× 428 0.3× 266 7.5k

Countries citing papers authored by Gaetano Finocchiaro

Since Specialization
Citations

This map shows the geographic impact of Gaetano Finocchiaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaetano Finocchiaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaetano Finocchiaro more than expected).

Fields of papers citing papers by Gaetano Finocchiaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaetano Finocchiaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaetano Finocchiaro. The network helps show where Gaetano Finocchiaro may publish in the future.

Co-authorship network of co-authors of Gaetano Finocchiaro

This figure shows the co-authorship network connecting the top 25 collaborators of Gaetano Finocchiaro. A scholar is included among the top collaborators of Gaetano Finocchiaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaetano Finocchiaro. Gaetano Finocchiaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sferruzza, Giacomo, et al.. (2025). Assessing time-trend bias in glioblastoma prognosis over 2 decades of clinical trials. Neuro-Oncology. 27(11). 2991–2999.
2.
Sferruzza, Giacomo, et al.. (2024). Reassessing the efficacy of bevacizumab in newly diagnosed glioblastoma: A systematic review and external pseudodata-based analysis. Neuro-Oncology Advances. 6(1). vdad174–vdad174. 4 indexed citations
3.
Lazzarini, Elisabetta, Domenico Alessandro Silvestris, Daniela Osti, et al.. (2023). Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors. Journal of Neuro-Oncology. 163(1). 47–59. 3 indexed citations
4.
Landoni, Elisa, Giovanni Fucà, Jian Wang, et al.. (2021). Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling. Cancer Immunology Research. 9(4). 441–453. 56 indexed citations
5.
Gagliardi, Filippo, Silvia Snider, Lina Raffaella Barzaghi, et al.. (2021). Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: A systematic review on current evidences and predicting factors. Critical Reviews in Oncology/Hematology. 165. 103431–103431. 13 indexed citations
6.
Gagliardi, Filippo, Silvia Snider, Lina Raffaella Barzaghi, et al.. (2021). Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors. Critical Reviews in Oncology/Hematology. 168. 103508–103508. 6 indexed citations
7.
Bianchessi, Donatella, Veronica Saletti, Rosina Paterra, et al.. (2020). Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients. Genes. 11(6). 671–671. 8 indexed citations
8.
Nava, Sara, Daniela Lisini, Simona Frigerio, et al.. (2020). PGE2 Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in Glioblastoma. Pharmaceutics. 12(3). 215–215. 4 indexed citations
9.
Liebelt, Brandon, Gaetano Finocchiaro, & Amy B. Heimberger. (2016). Principles of immunotherapy. Handbook of clinical neurology. 134. 163–181. 12 indexed citations
10.
Huang, Tianzhi, Angel A. Alvarez, Rajendra P. Pangeni, et al.. (2016). A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. Nature Communications. 7(1). 12885–12885. 75 indexed citations
11.
Labussière, Marianne, Blandine Boisselier, Karima Mokhtari, et al.. (2014). Combined analysis of TERT , EGFR , and IDH status defines distinct prognostic glioblastoma classes. Neurology. 83(13). 1200–1206. 178 indexed citations
12.
Favaro, Rebecca, Irene Appolloni, Serena Pellegatta, et al.. (2014). Sox2 Is Required to Maintain Cancer Stem Cells in a Mouse Model of High-Grade Oligodendroglioma. Cancer Research. 74(6). 1833–1844. 85 indexed citations
13.
Bacco, Francesca De, Elena Casanova, Enzo Médico, et al.. (2012). The MET Oncogene Is a Functional Marker of a Glioblastoma Stem Cell Subtype. Cancer Research. 72(17). 4537–4550. 111 indexed citations
14.
Salsano, Ettore, Laura Croci, Emanuela Maderna, et al.. (2007). Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1. Neuro-Oncology. 9(3). 298–307. 25 indexed citations
15.
Pellegatta, Serena, Pietro Luigi Poliani, Francesca Menghi, et al.. (2006). Neurospheres Enriched in Cancer Stem–Like Cells Are Highly Effective in Eliciting a Dendritic Cell–Mediated Immune Response against Malignant Gliomas. Cancer Research. 66(21). 10247–10252. 203 indexed citations
16.
Benedetti, Sara, Francesco DiMeco, Bianca Pollo, et al.. (1997). Limited Efficacy of the HSV-TK/GCV System for Gene Therapy of Malignant Gliomas and Perspectives for the Combined Transduction of the Interleukin-4 Gene. Human Gene Therapy. 8(11). 1345–1353. 57 indexed citations
17.
Finocchiaro, Gaetano. (1997). 23. Gene therapy of glioblastoma multiforme. The Italian Journal of Neurological Sciences. 18(4).
18.
Finocchiaro, Gaetano, et al.. (1993). cDNA cloning and mitochondrial import of the β‐subunit of the human electron‐transfer flavoprotein. European Journal of Biochemistry. 213(3). 1003–1008. 37 indexed citations
19.
Finocchiaro, Gaetano, et al.. (1984). Glutamate metabolism alterations in dominant OPCA. The Italian Journal of Neurological Sciences. 5. 134–140. 4 indexed citations
20.
Donato, Stefano Di, et al.. (1984). Skeletal muscle malic enzymes: A study in Friedreich's disease. The Italian Journal of Neurological Sciences. 5. 34–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Nistér Breakdown of academic impact, for papers by Sandra Pastorino Breakdown of academic impact, for papers by Brian Patrick O’Neill Breakdown of academic impact, for papers by Bianca Pollo Breakdown of academic impact, for papers by Roberto Pallini Breakdown of academic impact, for papers by Shakti Ramkissoon Breakdown of academic impact, for papers by Donald M. O’Rourke Breakdown of academic impact, for papers by Andrew J. Connolly Breakdown of academic impact, for papers by Karl H. Plate Breakdown of academic impact, for papers by Davide Schiffer
Rankless by CCL
2026